Literature DB >> 8738480

Inducibility of ethoxyresorufin deethylase and UDP-glucuronosyltransferase activities in two human hepatocarcinoma cell lines KYN-2 and Mz-Hep-1.

A Abid1, N Sabolovic, J Magdalou.   

Abstract

Two human hepatoma cell lines, KYN-2 and Mz-Hep-1 were characterized in terms of glucuronidation capacity and inducibility of cytochrome P4501A1/1A2 and several UDP-glucuronosyltransferases (UGTs). Cytochrome P4501A1/1A2 activity was measured using 7-ethoxyresorufin and that of UGTs with 16 different substrates. The effects of dimethyl sulfoxide (DMSO), 3-naphthoflavone, alpha-naphthoflavone, and rifampicin on these drug-metabolizing enzyme activities were studied. DMSO treatment increased in a dose-dependent manner the ethoxyresorufin O-deethylase (EROD) activity in KYN-2 cells, while an opposite effect was observed in Mz-Hep-1 cells. In KYN-2 cells, EROD was more responsive toward beta-naphthoflavone treatment in combination with DMSO. This activity was enhanced in Mz-Hep-1 cells more than 83 times by beta-naphthoflavone. The enhancement of EROD activity by DMSO and beta-naphthoflavone treatments of KYN-2 cells was abolished by alpha-naphthoflavone treatment. In Mz-Hep-1, only the inducing effect of beta-naphthoflavone was abolished by alpha-naphthoflavone treatment. Rifampicin treatment of KYN-2 cells reversed both the DMSO and beta-naphthoflavone effects on the EROD activity. Glucuronidation of steroids, bile acids, fatty acids and drugs was effective in KYN-2 and Mz-Hep-1 cells. Both 1-naphthol glucuronidation and the level of UGT1*6 protein detected by immunoblot and supporting this activity were lowered by DMSO treatment and increased by beta-naphthoflavone treatment in KYN-2 cells. In Mz-Hep-1 cells, DMSO and beta-naphthoflavone had no effect on 1-naphthol glucuronidation activity. DMSO, beta-naphthoflavone and rifampicin also affected the glucuronidation of various substrates supported by different UGT isoforms. These results indicate that KYN-2 and Mz-Hep-1 cells can be used as new in vitro models for the studies of drug metabolism and the regulation of the corresponding enzymes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738480     DOI: 10.1007/bf00143361

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  22 in total

1.  Substrate-selective induction of rabbit hepatic UDP-glucuronyltransferases by ethanol and other xenobiotics.

Authors:  B L Finley; P J Ashley; A G Neptune; G S Yost
Journal:  Biochem Pharmacol       Date:  1986-09-01       Impact factor: 5.858

Review 2.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.

Authors:  D R Nelson; T Kamataki; D J Waxman; F P Guengerich; R W Estabrook; R Feyereisen; F J Gonzalez; M J Coon; I C Gunsalus; O Gotoh
Journal:  DNA Cell Biol       Date:  1993 Jan-Feb       Impact factor: 3.311

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression and role of the human liver UDP-glucuronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in Escherichia coli.

Authors:  M Ouzzine; T Pillot; S Fournel-Gigleux; J Magdalou; B Burchell; G Siest
Journal:  Arch Biochem Biophys       Date:  1994-04       Impact factor: 4.013

6.  Expression of cytochrome P-450 enzymes in cultured human hepatocytes.

Authors:  F Morel; P H Beaune; D Ratanasavanh; J P Flinois; C S Yang; F P Guengerich; A Guillouzo
Journal:  Eur J Biochem       Date:  1990-07-31

7.  A new human pleomorphic hepatocellular carcinoma cell line, KYN-2.

Authors:  H Yano; M Maruiwa; T Murakami; K Fukuda; Y Ito; S Sugihara; M Kojiro
Journal:  Acta Pathol Jpn       Date:  1988-08

8.  A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.

Authors:  M Pritchard; S Fournel-Gigleux; G Siest; P Mackenzie; J Magdalou
Journal:  Mol Pharmacol       Date:  1994-01       Impact factor: 4.436

9.  Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family.

Authors:  T Ebner; B Burchell
Journal:  Drug Metab Dispos       Date:  1993 Jan-Feb       Impact factor: 3.922

10.  Differential induction of rat liver microsomal UDP-glucuronosyltransferase activites by various inducing agents.

Authors:  W Lilienblum; A K Walli; K W Bock
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

View more
  2 in total

1.  Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.

Authors:  K D Gallicano; J Sahai; V K Shukla; I Seguin; A Pakuts; D Kwok; B C Foster; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.

Authors:  M Teresa Donato; José V Castell
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 5.577

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.